多模态视网膜影像特征与精神分裂症的关联
该横断面分析基于AlzEye研究154 830名40岁以上患者,比较精神分裂症组与对照组的视网膜神经与血管指标。精神分裂症患者黄斑神经节细胞-内丛状层(mGC-IPL)更薄,血管分形维数降低,但血管差异多继发于糖尿病和高血压的高患病率。
要点
- 精神分裂症患者mGC-IPL较对照组薄4.05 μm,排除糖尿病者仍薄3.99 μm。
- 视网膜血管分形维数在精神分裂症组降低0.14单位,但排除糖尿病后差异消失。
- 精神分裂症组高血压(83.9% vs 48.0%)和糖尿病(75.1% vs 27.6%)患病率更高。
核心结论
- 精神分裂症患者存在可测量的视网膜神经和血管完整性差异。
- 视网膜血管差异主要继发于精神分裂症患者更高的糖尿病和高血压患病率。
研究设计与样本
- 横断面分析,数据来自AlzEye回顾性队列,纳入154 830名40岁及以上患者,链接眼科与住院数据。
- 最终分析纳入485例精神分裂症患者(747眼)和100 931名无精神分裂症个体(165 400眼)。
主要发现
- 精神分裂症组mGC-IPL较对照组薄-4.05 μm(95% CI,-5.40至-2.69;P=5.4×10-9)。
- 排除糖尿病患者后mGC-IPL差异仍为-3.99 μm(95% CI,-6.67至-1.30;P=.004)。
- 55岁及以下患者中mGC-IPL差异为-2.90 μm(95% CI,-5.55至-0.24;P=.03)。
- 校正分析中视网膜血管分形维数在精神分裂症组降低-0.14单位(95% CI,-0.22至-0.05;P=.001),排除糖尿病患者后该差异不存在。
临床怎么用
- 视网膜mGC-IPL厚度可能作为精神分裂症神经完整性辅助观察指标,但需进一步研究验证。
- 解读视网膜血管指标时需考虑糖尿病和高血压等共病的混杂影响。
局限性
- 横断面设计无法推断因果关系。
- 精神分裂症组糖尿病和高血压患病率显著更高,可能影响血管指标比较。
- 研究样本来自眼科医院就诊人群,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The potential association of schizophrenia with distinct retinal changes is of clinical interest but has been challenging to investigate because of a lack of sufficiently large and detailed cohorts. OBJECTIVE: To investigate the association between retinal biomarkers from multimodal imaging (oculomics) and schizophrenia in a large real-world population. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis used data from a retrospective cohort of 154 830 patients 40 years and older from the AlzEye study, which linked ophthalmic data with hospital admission data across England. Patients attended Moorfields Eye Hospital, a secondary care ophthalmic hospital with a principal central site, 4 district hubs, and 5 satellite clinics in and around London, United Kingdom, and had retinal imaging during the study period (January 2008 and April 2018). Data were analyzed from January 2022 to July 2022. MAIN OUTCOMES AND MEASURES: Retinovascular and optic nerve indices were computed from color fundus photography. Macular retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (mGC-IPL) thicknesses were extracted from optical coherence tomography. Linear mixed-effects models were used to examine the association between schizophrenia and retinal biomarkers. RESULTS: A total of 485 individuals (747 eyes) with schizophrenia (mean [SD] age, 64.9 years [12.2]; 258 [53.2%] female) and 100 931 individuals (165 400 eyes) without schizophrenia (mean age, 65.9 years [13.7]; 53 253 [52.8%] female) were included after images underwent quality control and potentially confounding conditions were excluded. Individuals with schizophrenia were more likely to have hypertension (407 [83.9%] vs 49 971 [48.0%]) and diabetes (364 [75.1%] vs 28 762 [27.6%]). The schizophrenia group had thinner mGC-IPL (-4.05 μm, 95% CI, -5.40 to -2.69; P = 5.4 × 10-9), which persisted when investigating only patients without diabetes (-3.99 μm; 95% CI, -6.67 to -1.30; P = .004) or just those 55 years and younger (-2.90 μm; 95% CI, -5.55 to -0.24; P = .03). On adjusted analysis, retinal fractal dimension among vascular variables was reduced in individuals with schizophrenia (-0.14 units; 95% CI, -0.22 to -0.05; P = .001), although this was not present when excluding patients with diabetes. CONCLUSIONS AND RELEVANCE: In this study, patients with schizophrenia had measurable differences in neural and vascular integrity of the retina. Differences in retinal vasculature were mostly secondary to the higher prevalence of diabetes and hypertension in patients with schizophrenia. The role of retinal features as adjunct outcomes in patients with schizophrenia warrants further investigation.
引用
- Wagner SK, Cortina-Borja M, Silverstein SM, et al. Association Between Retinal Features From Multimodal Imaging and Schizophrenia. JAMA Psychiatry. 2023. PMID: 36947045. doi:10.1001/jamapsychiatry.2023.0171
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。